Prevalence of hepatic steatosis and increased liver stiffness in Chinese children and adolescents: A national multicenter study [0.03%]
中国儿童和青少年肝脂肪变性和肝脏硬度增加的流行情况：一项全国多中心研究
Xiaolin Ye,Xiaoguo Li,Zhenhua Zhao et al.
Xiaolin Ye et al.
Myasthenia gravis following the initiation of statin therapy: A multinational self-controlled case series study [0.03%]
他汀类药物治疗后的重症肌无力：一项跨国自身控制的病例系列研究
Vincent Ka Chun Yan,Wanchun Xu,Yuta Taniguchi et al.
Vincent Ka Chun Yan et al.
Background: Evidence regarding the risk of new-onset myasthenia gravis (MG) following statin therapy initiation is limited. Objectives: ...
Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort [0.03%]
来自SCAPIS队列的瑞典代谢功能障碍相关肝脂肪变性肝病的流行率和危险因素研究
Oumarou Nabi,Jonas Spaak,Göran Bergström et al.
Oumarou Nabi et al.
Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally, but its prevalence and severity remain poorly characterized in the general populatio...
The urinary albumin-to-creatinine ratio can direct personalized prevention and treatment for cardiovascular and chronic kidney disease [0.03%]
尿白蛋白肌酐比值可指导心血管病和慢性肾病的精准防治
Holly J Kramer,George L Bakris
Holly J Kramer
Increased urinary albumin excretion is a strong predictor for cardiovascular events in persons with and without decreased glomerular filtration rate and can be assessed with the urinary albumin-to-creatinine ratio (UACR), which is a selecti...
The Swedish CArdioPulmonary bioImage Study re-examination: Rationale, design, methods, and management of incidental findings [0.03%]
瑞典心脏肺部图象研究（SCAPIS）复查：设计、方法及偶发症的处理原则
Elin Good,Göran Bergström,Anders Blomberg et al.
Elin Good et al.
Objectives: To describe the rationale, design and data collection procedures of the Swedish CArdioPulmonary bioImage Study (SCAPIS) re-examination, which, in its further scope, aims to quantify and explain the development...
Correction to "Soluble urokinase plasminogen activator receptor and interleukin-6 improve prediction of all-cause mortality and major adverse cardiovascular events in Type 1 diabetes" [0.03%]
“可溶性urokinase型纤溶酶原激活物受体和白细胞介素-6改善1型糖尿病全因死亡率和主要不良心血管事件的预测”一文的更正
Published Erratum
Journal of internal medicine. 2026 Jan 14. DOI:10.1111/joim.70065 2026
Identifying subjects at risk of liver cirrhosis via a range of thresholds for common fibrosis markers: A Welsh general population-based cohort study [0.03%]
基于威尔士普通人群的队列研究：通过一系列阈值识别肝硬化高危对象的常见纤维化标志物
Trevor A Hill,Joe West,Joanne R Morling et al.
Trevor A Hill et al.
Background: Liver disease is on the increase worldwide, with cirrhosis and liver cancer accounting for around 3.5% of all deaths. Objectives: ...
Aldosterone synthase inhibitors across the translational spectrum: Mechanistic foundations and emerging clinical applications [0.03%]
醛固酮合酶抑制剂的转化研究：机制基础与临床应用新进展
Matteo Merlo,Francesca Zoccatelli,Gabriele Costa et al.
Matteo Merlo et al.
Excess aldosterone is a key driver of cardiovascular, renal, and metabolic injury, promoting hypertension, myocardial fibrosis, proteinuria, and progressive chronic kidney disease (CKD). Conventional therapies, renin-angiotensin-aldosterone...
Non-steroidal anti-inflammatory drugs versus acetaminophen and risk of venous thromboembolism: An active comparator new user cohort study [0.03%]
非甾体抗炎药与对乙酰氨基酚和静脉血栓栓塞风险的关系：一组活性对照新用户队列研究
Yuichiro Matsuo,Akira Okada,Hideo Yasunaga
Yuichiro Matsuo
Background: Previous observational studies have reported an increased risk of venous thromboembolism (VTE) among non-steroidal anti-inflammatory drug (NSAID) users compared with non-users. However, these studies may have ...
Oskar Ragnarsson,C Christofer Juhlin,Tobias Åkerström et al.
Oskar Ragnarsson et al.
Primary aldosteronism (PA) is a common cause of hypertension. Compared to patients with essential hypertension, untreated PA is associated with a two- to fourfold greater risk of cardiovascular disease, renal failure, and death. PA is cause...